Breast

Viewing Page 2 of 5 | Showing Results 11 - 20 of 42

A011502: A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for Node Positive HER2 Negative Breast Cancer: The ABC Trial

This randomized phase III trial studies how well aspirin works in preventing the cancer from coming back (recurrence) in patients with human...

Timothy Byun, M.D.
  • St. Joseph Hospital of Orange
  • xSJH Southern California

ECM Mapping: Mapping Breast Cancer and Normal Breast Tissue Extracellular Matrix Proteins and Biomolecules

Cancer cells grow within a normal and orderly tissue microenvironment by producing and secretingchemicals that serve to favorably modify their...

Steve Martinez, M.D.

Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial for Low Risk DCIS: A Phase III Prospective Randomized Trial

Overdiagnosis and overtreatment resulting from mammographic screening have been estimated to be as high as 1 in 4 patients diagnosed with breast...

Jeanne Anderson MD
  • Alaska Research
  • Katmai Oncology Group
  • Providence Alaska Medical Center

A randomized phase II study to evaluate efficacy of T-DM1 with or without Palbociclib in the treatment of patients with metastatic HER2 positive breast cancer

Inclusion Criteria:Be informed of the investigational nature of the study and all pertinent aspects of the trialSign and provide written consent in...

Henry Kaplan, M.D.
  • Swedish Medical Center

A Phase II Randomized Trial of Olaparib (NSC-747856) Administered Concurrently with Radiotherapy versus Radiotherapy Alone for Inflammatory Breast Cancer

This phase II trial studies how well radiation therapy with or without olaparib works in treating patients with inflammatory breast cancer....

Gary Goodman, M.D.

The Pacific Cancer Research Consortium clinical trials are offered at multiple locations throughout Oregon, Washington, Alaska, California, and Idaho. To find a location near you, please contact the Patient Engagement Center at 844-552-2734.

iRISK Identifying Women at High Risk for Breast Cancer

Screening guidelines for women at average risk for breast cancer are well-established. Patients determined to be at high risk for breast cancer...

Steve Martinez, M.D.

A Phase Ib/II, Open-Label, Multicenter, Randomized Umbrella Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Hormone Receptor-Positive HER2-Negative Breast Cancer (MORPHEUS-HR+ Breast Cancer)

This study is designed to evaluate the efficacy, safety, and pharmacokinetics of several immunotherapy-based combination treatments in participants...

Alison Conlin, M.D.
  • Oncology and Hematology Care Westside
  • Providence Cancer Institute Franz Clinic

Prospective Evaluation of Carvedilol in Prevention of Cardiac Toxicity in Patients with Metastatic HER-2+ Breast Cancer, Phase III

The purpose of this study is to test whether carvedilol can reduce the occurrence of heart problems during your cancer treatment. Carvedilol...

Gary Goodman, M.D.

The Pacific Cancer Research Consortium clinical trials are offered at multiple locations throughout Oregon, Washington, Alaska, California, and Idaho. To find a location near you, please contact the Patient Engagement Center at 844-552-2734.

An Open-Label, Single-Arm, Phase 2 Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery

Inclusion Criteria:DCIS or Stage I-III primary invasive carcinoma of the breastPrimary surgical treatment is lumpectomy + SLNB or ALND --or--...

Claire Buchanan, M.D., FACS
  • Swedish Medical Center
Viewing Page 2 of 5 | Showing Results 11 - 20 of 42